David Shaw’s ResMed RMD Stock Holding History

David Shaw’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-30,000	Closed	-$7.32M	–	4794
2024 Q3	$7.32M	Hold	30,000	–	–	0.01%	1650
2024 Q2	$5.74M	Hold	30,000	–	–	0.01%	1742
2024 Q1	$5.94M	Hold	30,000	–	–	0.01%	1761
2023 Q4	$5.16M	Buy	30,000 +20,000	+200%	+$3.07M	﹤0.01%	1881
2023 Q3	$1.48M	Buy	+10,000	New	+$1.81M	﹤0.01%	2816
2022 Q2	–	Sell	-1,700	Closed	-$412K	–	5709
2022 Q1	$412K	Hold	1,700	–	–	﹤0.01%	4482
2021 Q4	$443K	Hold	1,700	–	–	﹤0.01%	4469
2021 Q3	$448K	Buy	+1,700	New	+$465K	﹤0.01%	4153
2020 Q3	–	Sell	-7,700	Closed	-$1.48M	–	4106
2020 Q2	$1.48M	Sell	7,700 -19,000	-71%	-$3.11M	﹤0.01%	2645
2020 Q1	$3.93M	Buy	26,700 +7,700	+41%	+$1.23M	0.01%	1644
2019 Q4	$2.94M	Buy	19,000 +4,100	+28%	+$591K	﹤0.01%	2164
2019 Q3	$2.01M	Buy	+14,900	New	+$1.95M	﹤0.01%	2343

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

David Shaw's RMD Position: Q2 2026 in Review

David Shaw reduced its ResMed (RMD) stake by 47% in Q2 2026, selling an estimated $1.13M and leaving 6,121 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3622.

David Shaw first reported a position in RMD in Q2 2013 and has held it in 45 quarters since. The position peaked at $97.2M in Q3 2023. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

David Shaw held 6,121 shares of ResMed worth $1.19M as of Q2 2026.
David Shaw sold 5,455 ResMed shares in Q2 2026, an estimated $1.13M.
ResMed made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3622 holding.
David Shaw first reported a position in ResMed in Q2 2013 and has held it in 45 quarters since.
David Shaw's ResMed position peaked at $97.2M in Q3 2023.
880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.